• Explore /
  • Poster
  • / Phase II study of avelumab plus intermittent axitinib in previously untreated patients with metastatic renal cell carcinoma (Tide-A study).

Phase II study of avelumab plus intermittent axitinib in previously untreated patients with metastatic renal cell carcinoma (Tide-A study).

Abstract Poster

Authors

null

Roberto Iacovelli

Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Roberto Iacovelli , Francesco Atzori , Umberto Basso , Melissa Bersanelli , Lucia Bonomi , Sergio Bracarda , Consuelo Buttigliero , Emanuela Fantinel , Fabio Calabro , Vincenzo Emanuele Chiuri , Giuseppe Di Lorenzo , Giuseppe Fornarini , Francesco Massari , Emanuele Naglieri , Cinzia Ortega , Giuseppe Procopio , Michele Milella , Matteo Santoni , Maria Giuseppa Vitale , Paolo Andrea Zucali

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr TPS762)

Abstract #

TPS762

Poster Bd #

K18

Abstract Disclosures

Similar Posters

First Author: Jennifer Allison

First Author: Axel Bex

First Author: Toni K. Choueiri

First Author: Shingo Hatakeyama